Takeda opens API facility in Ireland, its first outside Japan

摘要

IRELAND Takeda has opened a new cancer drug manufacturing plant in Dublin, Ireland. This marks the Japan-based group's first API facility outside of its home nation. The facility will produce Ninlaro, an oral combination therapy for multiple myeloma, for global distribution. The plant will take care of all steps in the process of producing the oncology treatment. This includes manufacturing the API, producing the drug, packaging and eventual supply.